$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| DISCUSSIONS WITH ACERTA PHARMA BV | 14 Dec 2015 |
| LATE-STAGE PIPELINE CONFERENCE CALL | 02 Dec 2015 |
| BLOCKLISTING INTERIM REVIEW | 01 Dec 2015 |
| TOTAL VOTING RIGHTS | 01 Dec 2015 |
| AZ ENTERS AGREEMENT W/ PERRIGO FOR ENTOCORT IN US | 23 Nov 2015 |
| FORM 6-K | 16 Nov 2015 |
| AZD9291 APPROVED BY THE US FDA | 13 Nov 2015 |
| ASTRAZENECA PRICES A $6 BILLION BOND ISSUE | 12 Nov 2015 |
| AZ ACQUIRES ZS PHARMA TO STRENGTHEN CVMD PORTFOLIO | 06 Nov 2015 |
| 3RD QUARTER RESULTS | 05 Nov 2015 |
| NOTICE OF RESULTS | 04 Nov 2015 |
| TOTAL VOTING RIGHTS | 02 Nov 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 27 Oct 2015 |
| FDA AD COM RECOMMENDS THE APPROVAL OF LESINURAD | 26 Oct 2015 |
| SAXA/DAPA FDC COMPLETE RESPONSE LETTER FROM FDA | 16 Oct 2015 |
| ASTRAZENECA COMPLETES DIVESTMENT OF CAPRELSA | 07 Oct 2015 |
| TOTAL VOTING RIGHTS | 01 Oct 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 01 Oct 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 28 Sep 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 28 Sep 2015 |
